1 in 4 Patients With NSCLC Respond Poorly to COVID-19 Vaccine 1 in 4 Patients With NSCLC Respond Poorly to COVID-19 Vaccine

About 1 in 4 patients with non –small cell lung cancer have an unsatisfactory antibody response to the Omicron variant following COVID-19 vaccination, reports a new study.MDedge News
Source: Medscape Hematology-Oncology Headlines - Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news